Scarica l'app Stockscreener
3.05
2.01%
0.06
Precedente Chiudi:
$2.99
Aprire:
$3.02
Volume 24 ore:
424.14K
Relative Volume:
0.72
Capitalizzazione di mercato:
$192.84M
Reddito:
$4.39M
Utile/perdita netta:
$-22.40M
Rapporto P/E:
-5.9827
EPS:
-0.5098
Flusso di cassa netto:
$-22.79M
1 W Prestazione:
+8.54%
1M Prestazione:
+65.76%
6M Prestazione:
+182.41%
1 anno Prestazione:
+845.74%
Intervallo 1D:
$2.98
$3.12
Intervallo di 1 settimana:
$2.6839
$3.12
Portata 52W:
$0.27
$3.45
Equillium Inc Stock (EQ) Company Profile
Nome
Equillium Inc
Settore
Industria
Telefono
(858) 412-5302
Indirizzo
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
3.05 | 192.84M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-23 | Iniziato | Oppenheimer | Outperform |
| 2026-04-16 | Iniziato | B. Riley Securities | Buy |
| 2026-04-14 | Iniziato | Raymond James | Strong Buy |
| 2026-04-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2026-03-13 | Iniziato | Roth Capital | Buy |
| 2026-02-25 | Iniziato | Stifel | Buy |
| 2025-03-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | Ripresa | Stifel | Buy |
| 2021-09-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-07-14 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-10 | Ripresa | Stifel | Buy |
| 2019-02-22 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Equillium Inc Borsa (EQ) Ultime notizie
23% Of This Equillium Insider's Holdings Were Sold - simplywall.st
Equillium Inc (EQ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Equillium Inc (EQ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Equillium Inc (EQ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Equillium Inc (EQ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equillium Inc (EQ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Equillium Inc (EQ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Equillium Inc (EQ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Equillium Inc (EQ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Equillium Inc. (EQ) Holds Steady at $2.81 – Key Support and Resistance Levels in FocusSystematic Flow - newsline.com
Equillium’s Lead Asset EQ504 Sees Growing Analyst Confidence Amid Pipeline ProgressDividend Cut Risk - newsline.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Insider Monkey
EQ Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
Equillium COO Christine Zedelmayer sells $42,736 in stock - Investing.com UK
Insider Sell: Stephen Connelly Sells 230,975 Shares of Equillium Inc (EQ) - GuruFocus
Equillium COO Christine Zedelmayer sells $42,736 in stock By Investing.com - Investing.com Nigeria
Equillium (NASDAQ: EQ) Form 144: insider resale activity, 200,000-share sale noted - Stock Titan
Equillium Insider Sold Shares Worth $723,830, According to a Recent SEC Filing - marketscreener.com
Equillium (EQ) COO sells 14,584 shares after exercising stock options - Stock Titan
Equillium (NASDAQ: EQ) CSO Stephen Connelly sells 230,975 shares in open market - Stock Titan
[144] Equillium, Inc. SEC Filing - Stock Titan
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory DiseaseSlideshow (NASDAQ:EQ) 2026-06-03 - Seeking Alpha
Equillium(EQ) Stock Options Chain | Quotes & News - Moomoo
Equillium Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
B. Riley Securities Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Equillium links AhR activation to miR-124 as EQ504 heads toward Phase 1 - MSN
Is Equillium's AhR/miR-124 Axis the Key to Unlocking Inflammatory Disease Treatment - Kavout
Equillium Insider Sold Shares Worth $267,209, According to a Recent SEC Filing - Moomoo
Leerink Partners upgrades Equillium (EQ) - MSN
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares - Investing.com Australia
Equillium principal accounting officer Tom Penny sells $191,750 in stock By Investing.com - Investing.com Nigeria
Equillium principal accounting officer Tom Penny sells $191,750 in stock - Investing.com
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares By Investing.com - Investing.com South Africa
Equillium (EQ) accounting officer sells 65,000 shares under 10b5-1 plan - Stock Titan
Equillium (EQ) director receives 70,000 options at $2.84 exercise price - Stock Titan
Equillium (EQ) director receives grant of 70,000 stock options at $2.84 - Stock Titan
[Form 4] Equillium, Inc. Insider Trading Activity - Stock Titan
Equillium (EQ) COO exercises options and sells 95,833 common shares - Stock Titan
Equillium (EQ) grants director 70,000 options vesting over a year - Stock Titan
Equillium (EQ) director Barbara Troupin receives grant of 70,000 stock options - Stock Titan
Equillium Shareholders Approve Reverse Split and Capital Changes - TipRanks
[8-K] Equillium, Inc. Reports Material Event - Stock Titan
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1 - Barchart.com
Equillium Inc Azioni (EQ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):